Ariel reports 8.5% stake in Prestige Consumer Healthcare (PBH)
Rhea-AI Filing Summary
Ariel Investments, LLC has reported beneficial ownership of 4,102,497 shares of Prestige Consumer Healthcare Inc common stock, representing 8.5% of the outstanding class as of December 31, 2025. Ariel has sole voting power over 3,672,254 shares and sole dispositive power over all 4,102,497 shares.
The filing explains that these securities are held for Ariel’s adviser clients, who are entitled to dividends and sale proceeds, and that no individual client has an economic interest in more than 5% of the shares. Ariel certifies the holdings are in the ordinary course of business and not for the purpose of changing or influencing control of Prestige Consumer Healthcare.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What percentage of Prestige Consumer Healthcare (PBH) does Ariel Investments control?
Ariel Investments reports beneficial ownership of 8.5% of Prestige Consumer Healthcare’s common stock. This percentage reflects 4,102,497 shares held for its advisory clients as of December 31, 2025, giving Ariel a significant institutional holder position in PBH.
Are Ariel Investments’ PBH holdings intended to influence company control?
Ariel certifies the PBH shares were acquired and are held in the ordinary course of business. The position is not held for the purpose of changing or influencing control of Prestige Consumer Healthcare, consistent with a passive institutional investment approach.
Who benefits economically from Ariel Investments’ stake in Prestige Consumer Healthcare (PBH)?
The economic benefits from Ariel’s PBH stake belong to its adviser clients. They receive dividends and sale proceeds related to the 4,102,497 reported shares, and no single client has an economic interest in more than 5% of Prestige Consumer’s common stock.
What type of investor is Ariel Investments in relation to Prestige Consumer (PBH)?
Ariel Investments is identified as an investment adviser filing on behalf of its clients. The Schedule 13G/A characterizes Ariel as a passive institutional holder, with the position held in the ordinary course and without a stated intent to influence corporate control.